News Focus
News Focus
Post# of 257558
Next 10
Followers 3
Posts 313
Boards Moderated 0
Alias Born 11/21/2011

Re: bladerunner1717 post# 228350

Wednesday, 01/22/2020 11:54:26 PM

Wednesday, January 22, 2020 11:54:26 PM

Post# of 257558
MGNX: Marg OS benefit (difference) was weak, and for 3L/2L HER2-BC there is already better choices (from SGEN and Roche), so most likely not than yes to be recommended by AC.

Overall, small chance for approval, IMO.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today